TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 117 filers reported holding TCR2 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $787,000 | +150090.8% | 524,184 | 0.0% | 0.00% | – |
| Q4 2022 | $524 | -99.9% | 524,184 | -0.3% | 0.00% | – |
| Q3 2022 | $947,000 | -53.3% | 525,748 | -24.9% | 0.00% | – |
| Q2 2022 | $2,030,000 | +3.0% | 699,890 | -1.9% | 0.00% | – |
| Q1 2022 | $1,970,000 | -54.6% | 713,613 | -23.3% | 0.00% | -100.0% |
| Q4 2021 | $4,339,000 | -50.5% | 930,835 | -9.7% | 0.00% | 0.0% |
| Q3 2021 | $8,768,000 | -19.0% | 1,030,360 | +56.3% | 0.00% | 0.0% |
| Q2 2021 | $10,821,000 | -25.2% | 659,411 | +0.7% | 0.00% | -50.0% |
| Q1 2021 | $14,457,000 | +1.6% | 654,814 | +42.3% | 0.00% | 0.0% |
| Q4 2020 | $14,232,000 | +178.7% | 460,147 | +74.4% | 0.00% | +100.0% |
| Q3 2020 | $5,107,000 | +35.5% | 263,874 | +7.5% | 0.00% | 0.0% |
| Q2 2020 | $3,770,000 | +116.0% | 245,559 | +8.9% | 0.00% | – |
| Q1 2020 | $1,745,000 | -41.0% | 225,501 | +8.8% | 0.00% | -100.0% |
| Q4 2019 | $2,960,000 | -2.5% | 207,304 | +2.6% | 0.00% | 0.0% |
| Q3 2019 | $3,036,000 | +9.0% | 202,016 | +5.0% | 0.00% | 0.0% |
| Q2 2019 | $2,786,000 | -19.5% | 192,337 | -3.2% | 0.00% | 0.0% |
| Q1 2019 | $3,463,000 | – | 198,721 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 6,741,964 | $208,528,000 | 18.01% |
| MPM ASSET MANAGEMENT LLC | 4,050,865 | $125,293,000 | 17.73% |
| Consonance Capital Management LP | 584,885 | $71,268,000 | 6.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 136,000 | $4,206,000 | 2.44% |
| Redmile Group, LLC | 2,832,888 | $87,621,000 | 1.06% |
| Altium Capital Management LP | 73,991 | $2,289,000 | 0.86% |
| PFM Health Sciences, LP | 775,794 | $23,995,000 | 0.84% |
| Soleus Capital Management, L.P. | 199,867 | $6,182,000 | 0.82% |
| MOODY ALDRICH PARTNERS LLC | 123,639 | $3,824,000 | 0.62% |
| Sofinnova Investments, Inc. | 333,707 | $10,322,000 | 0.61% |